Teewinot Capital Advisers, L.L.C. Bristol Myers Squibb CO Transaction History
Teewinot Capital Advisers, L.L.C.
- $940 Million
- Q1 2025
A detailed history of Teewinot Capital Advisers, L.L.C. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Teewinot Capital Advisers, L.L.C. holds 665,257 shares of BMY stock, worth $31.1 Million. This represents 4.32% of its overall portfolio holdings.
Number of Shares
665,257Holding current value
$31.1 Million% of portfolio
4.32%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,801Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.95 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.42 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.05 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.43 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...